Karen J. Hartwell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karen J. Hartwell has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Kathleen T. Brady
From the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC (Hartwell, Hanlon, Li, Borckardt, Canterberry, Priscriandaro, Maria, LeMatty, George, Brady); and the Ralph H. Johnson VA Medical Center, Charleston, SC (Hartwell, George, Brady)
5 shared publicationsMark S. George
From the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC (Hartwell, Hanlon, Li, Borckardt, Canterberry, Priscriandaro, Maria, LeMatty, George, Brady); and the Ralph H. Johnson VA Medical Center, Charleston, SC (Hartwell, George, Brady)
4 shared publications- Aimee L. McRae-Clark
Department of Psychiatry and Behavioral Sciences Medical University of South Carolina Charleston SC USA
3 shared publications Todd LeMatty
From the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC (Hartwell, Hanlon, Li, Borckardt, Canterberry, Priscriandaro, Maria, LeMatty, George, Brady); and the Ralph H. Johnson VA Medical Center, Charleston, SC (Hartwell, George, Brady)
3 shared publicationsXingbao Li
From the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC (Hartwell, Hanlon, Li, Borckardt, Canterberry, Priscriandaro, Maria, LeMatty, George, Brady); and the Ralph H. Johnson VA Medical Center, Charleston, SC (Hartwell, George, Brady)
3 shared publicationsJames J. Prisciandaro
From the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC (Hartwell, Hanlon, Li, Borckardt, Canterberry, Priscriandaro, Maria, LeMatty, George, Brady); and the Ralph H. Johnson VA Medical Center, Charleston, SC (Hartwell, George, Brady)
2 shared publications
Latest Publications
- 1 March 2022
- Published by Elsevier in Addictive Behaviors
- Vol. 126, 107181
Disparities in years of potential life lost to Drug-involved overdose deaths in South Carolina
- 1 March 2022
- Published by Elsevier in Addictive Behaviors
- Vol. 126, 107181
Disparities in years of potential life lost to Drug-involved overdose deaths in South Carolina
- 1 January 2016
- Published by Canadian Science Publishing in Journal of Psychiatry and Neuroscience
- Vol. 41 (1) , 48-55
Individualized real-time fMRI neurofeedback to attenuate craving in nicotine-dependent smokers
Background: Cue-induced craving plays an important role in relapse, and the neural correlates of cue-induced craving have been elucidated using fMRI. This study examined the utility of real-time fMRI (rtfMRI) neurofeedback to strengthen self-regulation of craving-related neural activation and cue-reactivity in cigarette smokers. Methods: Nicotine-dependent smokers were randomized to rtfMRI neurofeedback or to a no-feedback control group. Participants completed 3 neuroimaging visits. Within each visit, an initial run during which smoking-related cues were used to provoke craving, an individualized craving-related region of interest (ROI) in the prefrontal cortex or anterior cingulate cortex was identified. In the rtfMRI group, activity from the ROI was fed back via a visual display during 3 subsequent runs while participants were instructed to reduce craving during cue exposure. The control group had an identical experience with no feedback provided. Results: Forty-four nicotine-dependent smokers were recruited to participate in our study; data from the 33 participants who completed a 1-week follow-up visit were included in the analysis. Subjective craving ratings and cue-induced brain activation were lower in the rtfMRI group than in the control group. Limitations: As participants were not seeking treatment, clinical outcomes are lacking. Conclusion: Nicotine-dependent smokers receiving rtfMRI feedback from an individualized ROI attenuated smoking cue–elicited neural activation and craving, relative to a control group. Further studies are needed in treatment-seeking smokers to determine if this intervention can translate into a clinically meaningful treatment modality.
- 1 January 2016
- Published by Canadian Science Publishing in Journal of Psychiatry and Neuroscience
- Vol. 41 (1) , 48-55
Individualized real-time fMRI neurofeedback to attenuate craving in nicotine-dependent smokers
Background: Cue-induced craving plays an important role in relapse, and the neural correlates of cue-induced craving have been elucidated using fMRI. This study examined the utility of real-time fMRI (rtfMRI) neurofeedback to strengthen self-regulation of craving-related neural activation and cue-reactivity in cigarette smokers. Methods: Nicotine-dependent smokers were randomized to rtfMRI neurofeedback or to a no-feedback control group. Participants completed 3 neuroimaging visits. Within each visit, an initial run during which smoking-related cues were used to provoke craving, an individualized craving-related region of interest (ROI) in the prefrontal cortex or anterior cingulate cortex was identified. In the rtfMRI group, activity from the ROI was fed back via a visual display during 3 subsequent runs while participants were instructed to reduce craving during cue exposure. The control group had an identical experience with no feedback provided. Results: Forty-four nicotine-dependent smokers were recruited to participate in our study; data from the 33 participants who completed a 1-week follow-up visit were included in the analysis. Subjective craving ratings and cue-induced brain activation were lower in the rtfMRI group than in the control group. Limitations: As participants were not seeking treatment, clinical outcomes are lacking. Conclusion: Nicotine-dependent smokers receiving rtfMRI feedback from an individualized ROI attenuated smoking cue–elicited neural activation and craving, relative to a control group. Further studies are needed in treatment-seeking smokers to determine if this intervention can translate into a clinically meaningful treatment modality.
- 19 February 2013
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- Vol. 39 (2) , 92-98
Resisting the Urge to Smoke and Craving during a Smoking Quit Attempt on Varenicline: Results from a Pilot FMRI Study
Background: Varenicline has been shown to reduce cigarette craving during a quit attempt. Objectives: Use BOLD fMRI to explore differences in smoking cue reactivity at baseline and after five weeks of varenicline smoking cessation treatment. Methods: Treatment-seeking nicotine-dependent adult smokers underwent BOLD fMRI scans with block presentation of visual smoking, neutral, and rest cues under two conditions: craving or resisting the urge to smoke at baseline and following 5 weeks of standard varenicline therapy. Data were analyzed using FMRI Expert Analysis Tool, version 5.98 of Functional Magnetic Imaging of the Brain Software Library focused on the smoking vs. neutral cue contrast at the individual and group level, Z>2.3 with cluster threshold p=0.05. Results: Twenty-one participants were scanned at baseline and 16 completed the study; 10 were abstinent at the 2nd session, confirmed with urinary cotinine. In the Crave Condition no significant differences were found between the abstinent and non-abstinent groups at either time point. During the baseline Resist Condition, the abstinent group compared to the non-abstinent group demonstrated activation in a distributed network involved in alertness, learning and memory. Additionally, within the abstinent group, increased activation of the superior frontal gyrus was found at baseline compared to week 5. Conclusion: Successful smoking cessation with varenicline is associated with increased activation, prior to a quit attempt, in brain areas related to attentiveness and memory while resisting the urge to smoke Scientific Significance: Varenicline may exert effects by both reducing craving and enhancing resistance to smoking urges during cue-elicited craving.
- 19 February 2013
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- Vol. 39 (2) , 92-98
Resisting the Urge to Smoke and Craving during a Smoking Quit Attempt on Varenicline: Results from a Pilot FMRI Study
Background: Varenicline has been shown to reduce cigarette craving during a quit attempt. Objectives: Use BOLD fMRI to explore differences in smoking cue reactivity at baseline and after five weeks of varenicline smoking cessation treatment. Methods: Treatment-seeking nicotine-dependent adult smokers underwent BOLD fMRI scans with block presentation of visual smoking, neutral, and rest cues under two conditions: craving or resisting the urge to smoke at baseline and following 5 weeks of standard varenicline therapy. Data were analyzed using FMRI Expert Analysis Tool, version 5.98 of Functional Magnetic Imaging of the Brain Software Library focused on the smoking vs. neutral cue contrast at the individual and group level, Z>2.3 with cluster threshold p=0.05. Results: Twenty-one participants were scanned at baseline and 16 completed the study; 10 were abstinent at the 2nd session, confirmed with urinary cotinine. In the Crave Condition no significant differences were found between the abstinent and non-abstinent groups at either time point. During the baseline Resist Condition, the abstinent group compared to the non-abstinent group demonstrated activation in a distributed network involved in alertness, learning and memory. Additionally, within the abstinent group, increased activation of the superior frontal gyrus was found at baseline compared to week 5. Conclusion: Successful smoking cessation with varenicline is associated with increased activation, prior to a quit attempt, in brain areas related to attentiveness and memory while resisting the urge to smoke Scientific Significance: Varenicline may exert effects by both reducing craving and enhancing resistance to smoking urges during cue-elicited craving.
- 1 January 2013
- Published by American Psychological Association (APA) in Psychology of Addictive Behaviors
- Vol. 27 (2) , 501-509
Real-time fMRI in the treatment of nicotine dependence: A conceptual review and pilot studies.
Technical advances allowing for the analysis of functional MRI (fMRI) results in real time have led to studies exploring the ability of individuals to use neural feedback signals to modify behavior and regional brain activation. The use of real-time fMRI (rtfMRI) feedback has been explored for therapeutic benefit in a number of disease states, but to our knowledge, the potential therapeutic benefit of rtfMRI feedback in the treatment of addictive disorders has not been explored. This article will provide an overview of the development of rtfMRI and discussion of its potential uses in the treatment of addictions. We also describe a series of pilot studies that highlight some of the technical challenges in developing a rtfMRI feedback paradigm for use in addictions, specifically in nicotine dependence. Because the use of rtfMRI feedback is in its infancy, the work described is focused on establishing some of the basic parameters in optimizing the rtfMRI feedback, such as the type of feedback signal, region of interest for feedback and predicting which subjects are most likely to respond well to training. While rtfMRI feedback remains an intriguing possibility for the treatment of addictions, much work remains to be done in establishing its efficacy.
- 1 January 2013
- Published by American Psychological Association (APA) in Psychology of Addictive Behaviors
- Vol. 27 (2) , 501-509
Real-time fMRI in the treatment of nicotine dependence: A conceptual review and pilot studies.
Technical advances allowing for the analysis of functional MRI (fMRI) results in real time have led to studies exploring the ability of individuals to use neural feedback signals to modify behavior and regional brain activation. The use of real-time fMRI (rtfMRI) feedback has been explored for therapeutic benefit in a number of disease states, but to our knowledge, the potential therapeutic benefit of rtfMRI feedback in the treatment of addictive disorders has not been explored. This article will provide an overview of the development of rtfMRI and discussion of its potential uses in the treatment of addictions. We also describe a series of pilot studies that highlight some of the technical challenges in developing a rtfMRI feedback paradigm for use in addictions, specifically in nicotine dependence. Because the use of rtfMRI feedback is in its infancy, the work described is focused on establishing some of the basic parameters in optimizing the rtfMRI feedback, such as the type of feedback signal, region of interest for feedback and predicting which subjects are most likely to respond well to training. While rtfMRI feedback remains an intriguing possibility for the treatment of addictions, much work remains to be done in establishing its efficacy.
- Top Cited Papers
- 1 August 2012
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 169 (8) , 805-812
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in Cannabis-Dependent Adolescents
N-acetylcysteine (1,200 mg twice a day) was added to contingency management intervention and very brief weekly cessation counseling in an 8-week, double-blind, randomized, placebo-controlled trial ... Objective:Preclinical findings suggest that the over-the-counter supplement N-acetylcysteine (NAC), via glutamate modulation in the nucleus accumbens, holds promise as a pharmacotherapy for substan...
- 1 August 2012
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 169 (8) , 805-812
Top Cited PapersA Double-Blind Randomized Controlled Trial of N-Acetylcysteine in Cannabis-Dependent Adolescents
N-acetylcysteine (1,200 mg twice a day) was added to contingency management intervention and very brief weekly cessation counseling in an 8-week, double-blind, randomized, placebo-controlled trial ... Objective:Preclinical findings suggest that the over-the-counter supplement N-acetylcysteine (NAC), via glutamate modulation in the nucleus accumbens, holds promise as a pharmacotherapy for substan...
- 1 April 2012
- Published by Elsevier in Addictive Behaviors
- Vol. 37 (4) , 373-378
Motives for using: A comparison of prescription opioid, marijuana and cocaine dependent individuals
- 1 April 2012
- Published by Elsevier in Addictive Behaviors
- Vol. 37 (4) , 373-378
Motives for using: A comparison of prescription opioid, marijuana and cocaine dependent individuals
- 25 July 2011
- Published by Wiley in Addiction Biology
- Vol. 16 (4) , 654-666
Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers
Craving is a significant factor which can lead to relapse during smoking quit attempts. Attempts to resist urges to smoke during cue‐elicited craving have been shown to activate regions in the brain associated with decision‐making, anxiety regulation and visual processing. In this study, 32 treatment‐seeking, nicotine‐dependent smokers viewed blocks of smoking and neutral cues alternating with rest periods during magnetic resonance imaging scanning in a 3T Siemens scanner (Siemens AG, Erlangen, Bavaria, Germany). While viewing cues or control images, participants were instructed either to ‘allow yourself to crave’ or ‘resist craving.’ Data were analyzed with FSL 4.1.5, focused on the smoking cues versus neutral cues contrast, using cluster thresholding (Z > 2.3 and corrected cluster threshold of P = 0.05) at the individual and group levels. During the Crave condition, activation was seen on the left anterior cingulated cortex (LACC), medial prefrontal cortex, left middle cingulate gyrus, bilateral posterior cingulated gyrus and bilateral precuneus, areas associated with attention, decision‐making and episodic memory. The LACC and areas of the prefrontal cortex associated with higher executive functioning were activated during the Resist condition. No clear distinctions between group crave and resist analyses as a whole were seen without taking into account specific strategies used to resist the urge to smoke, supporting the idea that craving is associated with some degree of resisting the urge to smoke, and trying to resist is almost always accompanied by some degree of craving. Different strategies for resisting, such as distraction, activated different regions. Understanding the underlying neurobiology of resisting craving to smoke may identify new foci for treatments.
- 25 July 2011
- Published by Wiley in Addiction Biology
- Vol. 16 (4) , 654-666
Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers
Craving is a significant factor which can lead to relapse during smoking quit attempts. Attempts to resist urges to smoke during cue‐elicited craving have been shown to activate regions in the brain associated with decision‐making, anxiety regulation and visual processing. In this study, 32 treatment‐seeking, nicotine‐dependent smokers viewed blocks of smoking and neutral cues alternating with rest periods during magnetic resonance imaging scanning in a 3T Siemens scanner (Siemens AG, Erlangen, Bavaria, Germany). While viewing cues or control images, participants were instructed either to ‘allow yourself to crave’ or ‘resist craving.’ Data were analyzed with FSL 4.1.5, focused on the smoking cues versus neutral cues contrast, using cluster thresholding (Z > 2.3 and corrected cluster threshold of P = 0.05) at the individual and group levels. During the Crave condition, activation was seen on the left anterior cingulated cortex (LACC), medial prefrontal cortex, left middle cingulate gyrus, bilateral posterior cingulated gyrus and bilateral precuneus, areas associated with attention, decision‐making and episodic memory. The LACC and areas of the prefrontal cortex associated with higher executive functioning were activated during the Resist condition. No clear distinctions between group crave and resist analyses as a whole were seen without taking into account specific strategies used to resist the urge to smoke, supporting the idea that craving is associated with some degree of resisting the urge to smoke, and trying to resist is almost always accompanied by some degree of craving. Different strategies for resisting, such as distraction, activated different regions. Understanding the underlying neurobiology of resisting craving to smoke may identify new foci for treatments.